Nilai Aset Bersih Cocrystal Pharma (COCP)

Cocrystal Pharma, Inc. (COCP) operations are protected by US law, which eliminates geopolitical risks. The expert team focuses on patenting innovations and successful drug trials, while the key metric stands at 0.00. The company's price chart confirms a risk-mitigation strategy through the development of a broad spectrum of agents against various virus strains, including influenza and COVID-19.

For Cocrystal Pharma, Inc. (COCP), whose R&D expenditures for antiviral drug development are already priced in by the market, this indicator serves as a measure of the real value of net assets relative to speculative expectations. By analyzing the dynamics of the balance sheet capital structure, an investor can discern the gap between the market valuation and equity minus liabilities, enabling the timely identification of liquidity risk amid clinical trials.